Literature DB >> 11597930

Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids.

M Yeh1, N Leitinger, R de Martin, N Onai, K Matsushima, D K Vora, J A Berliner, S T Reddy.   

Abstract

Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (Ox-PAPC) upregulates a spectrum of inflammatory cytokines and adhesion molecules different from those induced by classic inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide. Interestingly, Ox-PAPC also induces the expression of a set of proteins similar to those induced by TNF-alpha or lipopolysaccharide, which include the chemokines monocyte chemotactic protein-1 (MCP-1) and interleukin (IL)-8. To elucidate the molecular mechanisms of Ox-PAPC-induced gene expression and to determine whether Ox-PAPC and other inflammatory mediators such as TNF-alpha utilize common signaling pathways, we examined the transcriptional regulation of IL-8 by Ox-PAPC and TNF-alpha in human aortic endothelial cells. Both Ox-PAPC and TNF-alpha induced the expression of IL-8 mRNA in a dose-dependent fashion; however, the kinetics of IL-8 mRNA accumulation between the 2 ligands differed. Ox-PAPC-induced IL-8 mRNA was seen as early as 30 minutes, peaked between 4 and 8 hours, and decreased substantially by 24 hours. In contrast, TNF-alpha-induced IL-8 mRNA synthesis was elevated at 30 minutes, peaked at 2 hours, and reached basal/undetectable levels by 6 hours. Actinomycin D experiments suggested that both Ox-PAPC and TNF-alpha regulate the expression of IL-8 at the transcriptional level. Furthermore, the half-life of IL-8 mRNA for both ligands was similar (<30 minutes), suggesting that mRNA stability was not responsible for the differences in the kinetics of IL-8 accumulation between the 2 ligands. Transient transfection studies with reporter constructs containing 1.48 kb of the IL-8 promoter identified an Ox-PAPC-specific response region between -133 and -1481 bp of the IL-8 promoter. In contrast, TNF-alpha activation of the IL-8 promoter was mediated almost entirely through the nuclear factor-kappaB and activation protein-1 response elements present between -70 and -133 bp of the IL-8 promoter. Thus, although Ox-PAPC and TNF-alpha both induced IL-8 synthesis, our data suggest that the 2 ligands utilize different mechanisms in the regulation of IL-8 transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597930     DOI: 10.1161/hq1001.097027

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  Paraoxonase-2 modulates stress response of endothelial cells to oxidized phospholipids and a bacterial quorum-sensing molecule.

Authors:  Juyong Brian Kim; Yu-Rong Xia; Casey E Romanoski; Sangderk Lee; YongHong Meng; Yi-Shou Shi; Noam Bourquard; Ke Wei Gong; Zachary Port; Victor Grijalva; Srinivasa T Reddy; Judith A Berliner; Aldons J Lusis; Diana M Shih
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

2.  Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids.

Authors:  Peter S Gargalovic; Minori Imura; Bin Zhang; Nima M Gharavi; Michael J Clark; Joanne Pagnon; Wen-Pin Yang; Aiqing He; Amy Truong; Shilpa Patel; Stanley F Nelson; Steve Horvath; Judith A Berliner; Todd G Kirchgessner; Aldons J Lusis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

3.  Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis.

Authors:  Oscar L Volger; Joost O Fledderus; Natasja Kisters; Ruud D Fontijn; Perry D Moerland; Johan Kuiper; Theo J van Berkel; Ann-Pascale J J Bijnens; Mat J A P Daemen; Hans Pannekoek; Anton J G Horrevoets
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

4.  Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells.

Authors:  A Loboda; A Jazwa; B Wegiel; A Jozkowicz; J Dulak
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-09-30       Impact factor: 1.770

5.  MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome.

Authors:  Sanjukta Ghosh; David Gregory; Alexia Smith; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

6.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

Review 7.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

8.  Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids.

Authors:  Wendy Tseng; Jinxiu Lu; Gail A Bishop; Andrew D Watson; Andrew P Sage; Linda Demer; Yin Tintut
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

9.  Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: implication of chemical components and NF-kappaB signaling.

Authors:  Rongsong Li; Zhi Ning; Rohit Majumdar; Jeffery Cui; Wakako Takabe; Nelson Jen; Constantinos Sioutas; Tzung Hsiai
Journal:  Part Fibre Toxicol       Date:  2010-03-22       Impact factor: 9.400

10.  Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene.

Authors:  Lei Yuan; Vesna Nikolova-Krstevski; Yumei Zhan; Maiko Kondo; Manoj Bhasin; Laya Varghese; Kiichiro Yano; Chris V Carman; William C Aird; Peter Oettgen
Journal:  Circ Res       Date:  2009-04-09       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.